Product Information

AMLODIPINE-OLMESARTAN 10-40 MG is a generic product labeled by Micro Labs Limited, priced at $0.3161 per EA under NDC 42571023830. Its NADAC has been published 402 times since Dec 12, 2018.

FDA first approved this application on Nov 2, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 10-40 MG

Amlodipine and Olmesartan Medoxomil
$0.3161per EA

Strength

10; 40 mg/1; mg/1

Manufacturer

Micro Labs Limited

NDC

42571023830

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207435

FDA Approved

11/2/2017

TE Code

AB

On Market Since

1/1/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has been published 402 times since Dec 12, 2018, and over the history we have for it it has declined 52.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3161 per EA
All-time high$0.8711 (Jan 15, 2020)
All-time low$0.2641 (Jan 17, 2024)
52-week high$0.3755
52-week low$0.3156
Median price$0.4306
Average price$0.4923
Largest weekly change+47.0% (Nov 22, 2023)
Weeks tracked402
Tracking sinceDec 12, 2018

Price History

1W

-4.1%

1M

-4.1%

3M

-7.3%

6M

-12.6%

1Y

-15.8%

3Y

-18.2%

5Y

-39.9%

All

-52.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-40 MG, manufactured by Micro Labs Limited, is $0.3161 per EA (NDC 42571023830), effective Aug 19, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has declined 52.6%. It has been tracked across 402 weekly CMS publications since Dec 12, 2018.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-40 MG?

Since Dec 12, 2018, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has ranged from a low of $0.2641 (Jan 17, 2024) to a high of $0.8711 (Jan 15, 2020), with a median of $0.4306 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-40 MG?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-40 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-40 MG?

AMLODIPINE-OLMESARTAN 10-40 MG (NDC 42571023830) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.